Alterity(ATHE)

1.9485 -0.0515 -2.575%

今开:2.02昨收:2.0
最高:2.02 最低:1.93
涨停价:0.0跌停价:0.0
总市值:1.4232996E7

Alterity的热门讨论

财报披露

Alterity(ATHE)04-29 18:25

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036798  Act: 34  Size: 37 KB 网页链接查看全文

确定性required04-11 18:52

$Alterity(ATHE)$ 小市值,大故事查看全文

财报披露

Alterity(ATHE)04-17 18:05

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-033566  Act: 34  Size: 58 KB 网页链接查看全文

财报披露

Alterity(ATHE)05-09 18:05

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040963  Act: 34  Size: 37 KB 网页链接查看全文

财报披露

Alterity(ATHE)03-04 21:05

$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-019255  Act: 34  Size: 42 KB 网页链接查看全文

财报披露

Alterity(ATHE)05-23 18:05

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046048  Act: 34  Size: 44 KB 网页链接查看全文

财报披露

Alterity(ATHE)03-26 20:05

$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-025771  Act: 34  Size: 29 KB 网页链接查看全文

财报披露

Alterity(ATHE)04-15 20:05

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032741  Act: 34  Size: 58 KB 网页链接查看全文

财报披露

Alterity(ATHE)03-15 18:15

$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-022723  Act: 34  Size: 1 MB 网页链接查看全文

财报披露

Alterity(ATHE)03-04 21:05

$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-019252  Act: 34  Size: 62 KB 网页链接查看全文

1 2

Alterity的最新讨论

美股狙击2021-07-02 01:27

$Alterity医疗(ATHE)$ 坚韧不拔,永不言弃查看全文

美股狙击2021-07-01 22:43

$Alterity医疗(ATHE)$ 高抛低吸你就是赢家查看全文

鲜克有终72021-07-01 18:51

$Alterity医疗(ATHE)$ 估摸着是这个原因涨的查看全文

Linktu2021-02-28 09:21

$Alterity医疗(ATHE)$ 替代性疾病的主要候选药物ATH434(以前称为PBT434)是新一代小分子药物中的第一个,旨在抑制与神经退行性病变有关的病理蛋白的聚集。ATH434已显示可通过在大脑中重新分配不稳定的铁减少疾病动物模型中α-突触核蛋白和tau蛋白的异常积累。这样,它就有可能治疗帕金森氏病和非...查看全文

皮皮虾皮2021-02-18 21:54

$Alterity医疗(ATHE)$ Nice look at the chart. Eyes on查看全文

Linktu2021-02-18 21:14

$Alterity医疗(ATHE)$ 很好平稳的上升走势,值得持有等待查看全文

Linktu2021-02-11 07:50

$Alterity医疗(ATHE)$ 获得Michael J. Fox基金会的拨款,用于帕金森氏症的研究基于脑铁成像,确定针对帕金森氏病(PD)的主要药物候选药物ATH434的最佳剂量。查看全文

1 2 3

Alterity的新闻

Alterity Therapeutics(ATHE.US)盘前大涨近40%

格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接

Alterity的公告

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046048  Act: 34  Size: 44 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040963  Act: 34  Size: 37 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-037462  Act: 34  Size: 210 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036798  Act: 34  Size: 37 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036801  Act: 34  Size: 53 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-033566  Act: 34  Size: 58 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032741  Act: 34  Size: 58 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032316  Act: 34  Size: 317 KB 网页链接

财报披露

$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032317  Act: 34  Size: 215 KB 网页链接

财报披露

$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-025771  Act: 34  Size: 29 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30